These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6209428)

  • 21. Transurethral microwave treatment for benign prostatic hypertrophy: a randomised controlled clinical trial.
    Bdesha AS; Bunce CJ; Kelleher JP; Snell ME; Vukusic J; Witherow RO
    BMJ; 1993 May; 306(6888):1293-6. PubMed ID: 7686065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiandrogenic treatment of benign prostatic hyperplasia: a placebo controlled trial.
    Ostri P; Swartz R; Meyhoff HH; Petersen JH; Lindgård G; Frimodt-Møller C; Andersson T; Nielsen MS
    Urol Res; 1989; 17(1):29-33. PubMed ID: 2466359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost].
    Maekawa M; Kishimoto T; Yasumoto R; Wada S; Harada T; Ohara T; Okajima E; Hirao Y; Ohzono S; Shimada K
    Hinyokika Kiyo; 1990 Apr; 36(4):495-516. PubMed ID: 1696065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urodynamic effects of doxazosin in men with lower urinary tract symptoms and benign prostatic obstruction. Results from three double-blind placebo-controlled studies.
    Abrams P
    Eur Urol; 1997; 32(1):39-46. PubMed ID: 9266230
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alfuzosin in the treatment of benign prostatic hyperplasia: effects on symptom scores, urinary flow rates and residual volume. A multicentre, double-blind, placebo-controlled trial. ALFECH Study Group.
    Hansen BJ; Nordling J; Mensink HJ; Walter S; Meyhoff HH
    Scand J Urol Nephrol Suppl; 1994; 157():169-76. PubMed ID: 7524141
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group.
    Kawabe K; Ueno A; Takimoto Y; Aso Y; Kato H
    J Urol; 1990 Oct; 144(4):908-11; discussion 911-2. PubMed ID: 1697914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomised, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. Beta-sitosterol Study Group.
    Berges RR; Windeler J; Trampisch HJ; Senge T
    Lancet; 1995 Jun; 345(8964):1529-32. PubMed ID: 7540705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect on urapidil on benign prostatic hypertrophy: a multicenter, double-blind study.
    Kawabe K; Tsuchida S; Shimazaki J; Morita T; Yasuda K; Kageyama S
    Urol Int; 1993; 50(1):27-32. PubMed ID: 7679532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenoxybenzamine in prostatic hypertrophy. A double-blind study.
    Ferrie BG; Paterson PJ
    Br J Urol; 1987 Jan; 59(1):63-5. PubMed ID: 2435356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pooled analysis of individual patient data from registrational trials of silodosin in the treatment of non-neurogenic male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH).
    Novara G; Chapple CR; Montorsi F
    BJU Int; 2014 Sep; 114(3):427-33. PubMed ID: 24571313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urtica dioica for treatment of benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled, crossover study.
    Safarinejad MR
    J Herb Pharmacother; 2005; 5(4):1-11. PubMed ID: 16635963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of isosorbide dinitrate on the urinary flow rate in patients with benign prostatic hyperplasia.
    Roshani A; Khosropanah I; Salehi M; Kamran AN
    Urol J; 2010; 7(3):183-7. PubMed ID: 20845295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The clinical and flowmetric results of the treatment of benign prostatic hyperplasia with doxazosin].
    Salinas Casado J; Esteban Fuertes M; Virseda Chamorro M; Ramírez Fernández JC; Salomon Moh'd S; Luengo Alpuente S; Resel Estévez L
    Arch Esp Urol; 1999 Sep; 52(7):739-48. PubMed ID: 10540764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tadalafil on storage and voiding function in patients with male lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A urodynamic-based study.
    Matsukawa Y; Majima T; Matsuo K; Funahashi Y; Kato M; Yamamoto T; Gotoh M
    Int J Urol; 2018 Mar; 25(3):246-250. PubMed ID: 29164680
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pikamilone treatment of benign prostatic hyperplasia].
    Tolstova SS
    Urologiia; 1999; (5):6-7. PubMed ID: 11150159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of candicidin on the human benign hypertrophied prostate gland.
    Keshin JG
    Int Surg; 1973 Feb; 58(2):116-22. PubMed ID: 4119813
    [No Abstract]   [Full Text] [Related]  

  • 38. [Peptide geroprotector application for treatment of elderly and senile patients with prostatic hyperplasia].
    Gomberg VG; Ryzhak VG; Liutov RV
    Adv Gerontol; 2013; 26(3):476-80. PubMed ID: 24640697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of the antihypercholesterolemic drug, Probucol, in benign prostatic hyperplasia.
    Resnick MI; Jackson JE; Watts LE; Boyce WH
    J Urol; 1983 Jan; 129(1):206-9. PubMed ID: 6186824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Double-blind trial of the efficacy and tolerability of doxazosin in the gastrointestinal therapeutic system, doxazosin standard, and placebo in patients with benign prostatic hyperplasia.
    Andersen M; Dahlstrand C; Høye K
    Eur Urol; 2000 Oct; 38(4):400-9. PubMed ID: 11025377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.